Reaction Details Report a problem with these data
Target
N-formyl peptide receptor 2
Ligand
BDBM350526
Substrate
n/a
Meas. Tech.
FLIPR
EC50
96000±n/a nM
Citation
Beard, RL; Donello, JE; Viswanath, V Use of agonists of formyl peptide receptor 2 for treating ocular inflammatory diseases US Patent US10208071 Publication Date 2/19/2019
More Info.:
Target
Name:
N-formyl peptide receptor 2
Synonyms:
ALXR, FPRL1, FPR2 | FMLP-related receptor I FMLP-R-I | FPR2 | FPR2_HUMAN | FPRH1 | FPRL1 | Formyl Peptide Receptor-Like 1 | HM63 | LXA4 receptor | LXA4R | Lipoxin A4 receptor | Lipoxin A4 receptor (LXA4) | RFP | hFPRL
Type:
G Protein-Coupled Receptor (GPCR)
Mol. Mass.:
38968.35
Organism:
Homo sapiens (Human)
Description:
P25090
Residue:
351
Sequence:
METNFSTPLNEYEEVSYESAGYTVLRILPLVVLGVTFVLGVLGNGLVIWVAGFRMTRTVTTICYLNLALADFSFTATLPFLIVSMAMGEKWPFGWFLCKLIHIVVDINLFGSVFLIGFIALDRCICVLHPVWAQNHRTVSLAMKVIVGPWILALVLTLPVFLFLTTVTIPNGDTYCTFNFASWGGTPEERLKVAITMLTARGIIRFVIGFSLPMSIVAICYGLIAAKIHKKGMIKSSRPLRVLTAVVASFFICWFPFQLVALLGTVWLKEMLFYGKYKIIDILVNPTSSLAFFNSCLNPMLYVFVGQDFRERLIHSLPTSLERALSEDSAPTNDTAANSASPPAETELQAM
Inhibitor
Name:
BDBM350526
Synonyms:
N-(4-bromophenyl)-2-(4,4-diethyl- 2,5-dioxoimidazolidin-1-yl)acetamide | US10208071, Table 3.2 | US10434112, Table 3.2 | US10799518, Structure TABLE 3.2
Type:
Small organic molecule
Emp. Form.:
C15H18BrN3O3
Mol. Mass.:
368.226
SMILES:
CCC1(CC)NC(=O)N(CC(=O)Nc2ccc(Br)cc2)C1=O